Newborn Screening for Sickle Cell Disease: Technical and Legal Aspects of a German Pilot Study with 38,220 Participants

Sickle cell disease (SCD) does not occur in the indigenous German population, but with the increasing number of immigrants from countries at high risk for hemoglobinopathies, the question emerges whether or not a newborn screening program (NBS) for SCD disease should be initiated in Germany anyhow....

Descripción completa

Detalles Bibliográficos
Autores principales: Frömmel, Claudia, Brose, Annemarie, Klein, Jeannette, Blankenstein, Oliver, Lobitz, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132432/
https://www.ncbi.nlm.nih.gov/pubmed/25147811
http://dx.doi.org/10.1155/2014/695828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132432/
https://www.ncbi.nlm.nih.gov/pubmed/25147811
http://dx.doi.org/10.1155/2014/695828

Ejemplares similares